Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.

RATIONALE Pulmonary nontuberculous mycobacteria (PNTM) are an important cause of morbidity among older adults in the United States, but national prevalence estimates are lacking. OBJECTIVES To describe the prevalence and trends of PNTM disease among adults aged 65 years or older throughout the United States. METHODS A nationally representative 5% sample of Medicare Part B beneficiaries was analyzed from 1997 to 2007. Demographic and medical claims data were compiled and prevalence estimates for PNTM and selected comorbidities were calculated and trends over time evaluated. Logistic regression was used to identify demographic and geographic factors associated with PNTM. MEASUREMENTS AND MAIN RESULTS From 1997 to 2007, the annual prevalence significantly increased from 20 to 47 cases/100,000 persons, or 8.2% per year. The period prevalence was 112 cases/100,000 persons, although prevalence was twofold higher among Asians/Pacific Islanders than among whites (228 vs. 116 cases/100,000 persons). Western states had the highest period prevalence at 149 cases/100,000 persons, with Hawaii having the highest prevalence at 396 cases/100,000 persons, followed by southeastern states, which had a period prevalence of 131 cases/100,000 persons. PNTM cases had more comorbid conditions than noncases and were 40% more likely to die than noncases. Women were 1.4 times more likely to be a PNTM case than men. Relative to whites, Asians/Pacific Islanders were twice as likely to be a case, whereas blacks were half as likely. CONCLUSIONS The prevalence of PNTM is increasing across all regions of the United States and among both men and women. Significant racial/ethnic and geographic differences suggest important gene-environment interactions.

[1]  Li‐Na Lee,et al.  Disease caused by non-tuberculous mycobacteria in a university hospital in Taiwan, 1997–2003 , 2006, Epidemiology and Infection.

[2]  E. Oren,et al.  Epidemiology of urban tuberculosis in the United States, 2000-2007. , 2011, American journal of public health.

[3]  Robert Horsburgh,et al.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.

[4]  R. Thomson.  Changing Epidemiology of Pulmonary Nontuberculous Mycobacteria Infections , 2010, Emerging infectious diseases.

[5]  S. Holland,et al.  Trends In Bronchiectasis Among Medicare Beneficiaries In The United States, 2000-2007 , 2011, ATS 2011.

[6]  N. Lurie,et al.  Racial variation in quality of care among Medicare+Choice enrollees. , 2002, Health affairs.

[7]  A. Ishizaka,et al.  Specific HLA in pulmonary MAC infection in a Japanese population. , 2000, American journal of respiratory and critical care medicine.

[8]  B. Parker,et al.  Epidemiology of infection by nontuberculous mycobacteria. Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum in acid, brown-water swamps of the southeastern United States and their association with environmental variables. , 1992, The American review of respiratory disease.

[9]  A. Zaslavsky,et al.  Health Risks, Chronic Diseases, and Access to Care Among US Pacific Islanders , 2010, Journal of General Internal Medicine.

[10]  Rebecca Smith-Bindman,et al.  Racial and ethnic differences in breast cancer survival , 2008, Cancer.

[11]  M. Raffeld,et al.  Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. , 2008, American journal of respiratory and critical care medicine.

[12]  T. Marras,et al.  Nontuberculous Mycobacterial Lung Infections in Ontario, Canada: Clinical and Microbiological Characteristics , 2010, Lung.

[13]  E. Tortoli.  Clinical manifestations of nontuberculous mycobacteria infections. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  Roger Baxter,et al.  The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti‐tumor necrosis factor therapy , 2011, Pharmacoepidemiology and drug safety.

[15]  J. Fenton,et al.  Geographic variation of racial/ethnic disparities in colorectal cancer testing among medicare enrollees , 2011, Cancer.

[16]  Ji‐Hyun Lee,et al.  Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[17]  J. Falkinham.  Impact of human activities on the ecology of nontuberculous mycobacteria. , 2010, Future microbiology.

[18]  C. Palmer,et al.  An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. , 1969, The American review of respiratory disease.

[19]  H. Sohn,et al.  High virulent clinical isolates of Mycobacterium abscessus from patients with the upper lobe fibrocavitary form of pulmonary disease. , 2009, Microbial pathogenesis.

[20]  D. Weber,et al.  Utility of International Classification of Diseases, Ninth Revision, Clinical Modification codes for communicable disease surveillance. , 2010, American journal of epidemiology.

[21]  E. Moy,et al.  Community variation: disparities in health care quality between Asian and white medicare beneficiaries. , 2008, Health affairs.

[22]  M. Sakatani.  [The epidemiology of pulmonary disease caused by Mycobacterium avium complex in Japan]. , 1993, Kekkaku : [Tuberculosis].

[23]  K. Winthrop,et al.  Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. , 2010, American journal of respiratory and critical care medicine.

[24]  Mary Ann Blosky,et al.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. , 2010, American journal of respiratory and critical care medicine.

[25]  D. Mannino,et al.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[26]  T. Marras,et al.  Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997–2003 , 2007, Thorax.

[27]  Xianglin L. Du,et al.  Racial disparities in colorectal cancer survival , 2010, Cancer.

[28]  M. Yakrus,et al.  Nontuberculous mycobacterial disease following hot tub exposure. , 2001, Emerging infectious diseases.

[29]  Qing X. Li,et al.  Polycyclic aromatic hydrocarbon-degrading species isolated from Hawaiian soils: Mycobacterium crocinum sp. nov., Mycobacterium pallens sp. nov., Mycobacterium rutilum sp. nov., Mycobacterium rufum sp. nov. and Mycobacterium aromaticivorans sp. nov. , 2009, International journal of systematic and evolutionary microbiology.

[30]  J. Yim,et al.  Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[31]  S. Field,et al.  Mycobacterium avium complex pulmonary disease in patients without HIV infection. , 2004, Chest.

[32]  David W. Hosmer,et al.  Applied Logistic Regression , 1991 .

[33]  K. Winthrop,et al.  Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy , 2009, Emerging infectious diseases.

[34]  S. Field,et al.  Lung disease due to the more common nontuberculous mycobacteria. , 2006, Chest.

[35]  C. Husten,et al.  Cigarette smoking among adults--United States, 2002. , 2004, MMWR. Morbidity and mortality weekly report.

[36]  B. Currie,et al.  Nontuberculous mycobacterial disease in northern Australia: a case series and review of the literature. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  J. Yue,et al.  Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008. , 2010, Chinese medical journal.

[38]  D. Hoaglin,et al.  Mycobacterium avium complex, an emerging pathogen in Massachusetts , 1985, Journal of clinical microbiology.

[39]  S. Holland,et al.  Prevalence Of Pulmonary Nontuberculous Mycobacterial Infections Among U.S. Medicare Beneficiaries, 1997-2007 , 2011, ATS 2011.

[40]  J. Falkinham.  Nontuberculous mycobacteria in the environment. , 2002, Clinics in chest medicine.

[41]  S. Holland,et al.  Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007. , 2011, Chest.

[42]  L. Saiman,et al.  Epidemiology of Nontuberculous Mycobacteria in Patients without HIV Infection, New York City , 2008, Emerging infectious diseases.

[43]  Li-Mei Chen.  Is there disparity in physician service use? A comparison of Hispanic and white Medicare beneficiaries. , 2010, Health & social work.

[44]  C. Steiner,et al.  Nontuberculous Mycobacteria–associated Lung Disease in Hospitalized Persons, United States, 1998–2005 , 2009, Emerging infectious diseases.

[45]  S. Pang.  Mycobacterium kansasii infections in Western Australia (1962-1987). , 1991, Respiratory medicine.

[46]  P. Barnes,et al.  Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[47]  J. Falkinham.  Nontuberculous Mycobacteria from Household Plumbing of Patients with Nontuberculous Mycobacteria Disease , 2011, Emerging infectious diseases.

[48]  J. Escarce,et al.  Racial differences in the elderly's use of medical procedures and diagnostic tests. , 1993, American journal of public health.

[49]  C. Horsburgh,et al.  Protection from Mycobacterium avium complex disease in human immunodeficiency virus-infected persons with a history of tuberculosis. , 1996, The Journal of infectious diseases.

[50]  R. Good.  Isolation of Nontuberculous Mycobacteria in the United States, 1979 , 1980 .